{"id":2270,"date":"2026-06-10T22:00:00","date_gmt":"2026-06-11T01:00:00","guid":{"rendered":"https:\/\/sevenresiduosaude.com.br\/blog\/?p=2270"},"modified":"2026-06-10T22:00:00","modified_gmt":"2026-06-11T01:00:00","slug":"rss-clinica-medicina-endocrinologia-adulto-dm2-obesidade-tireoide-sglt2i-glp-1-tirzepatide","status":"publish","type":"post","link":"https:\/\/sevenresiduosaude.com.br\/blog\/rss-clinica-medicina-endocrinologia-adulto-dm2-obesidade-tireoide-sglt2i-glp-1-tirzepatide\/","title":{"rendered":"RSS endo adulto: DM2, GLP-1, tirzep, SGLT2i"},"content":{"rendered":"

A regula\u00e7\u00e3o brasileira de RSS \u00e9 frequentemente subaproveitada por gestores de cl\u00ednicas de endocrinologia adulto que reduzem RSS a descarte de seringa e gaze<\/strong>. Em 2026, h\u00e1 um cen\u00e1rio desafiador \u2014 cl\u00ednicas de endocrinologia adulto<\/strong> + DM2 diabetes mellitus tipo 2 + obesidade Class I\/II\/III + s\u00edndrome metab\u00f3lica<\/strong> + GLP-1 RA semaglutida Ozempic+Rybelsus oral+Wegovy obesidade + liraglutida Victoza\/Saxenda + dulaglutida Trulicity + tirzepatide Mounjaro\/Zepbound GLP-1+GIP dual + retatrutide GIP+GLP-1+glucagon triple LY3437943<\/strong> + SGLT2i empagliflozin Jardiance + dapagliflozin Forxiga + canagliflozin Invokana<\/strong> + insulina basal Tresiba degludec + Toujeo glargina U-300 + Lantus + Levemir + Apidra + Lispro+Asparte+Glulisina<\/strong> + tireoide hipo+hiper+n\u00f3dulo+Graves+Hashimoto<\/strong> + adrenal+pituit\u00e1ria+Cushing+Addison+osteoporose+hipogonadismo masculino+menopausa<\/strong> geram fluxos heterog\u00eaneos de RSS Grupo A1 (sangue venoso glicemia jejum+p\u00f3s-prandial+HbA1c+TSH+T4L+T3+TPO+TgAb+ACTH+cortisol+FSH+LH+testosterona+estradiol+progesterona+PRL+IGF-1+vit D 25-OH+PTH+Ca+P) + Grupo A2 (urina 24h cortisol+catecolaminas+metanefrinas+aldosterona+iod\u00faria) + Grupo B (DPP-4i sitagliptina Januvia+linagliptina Trajenta + GLP-1 RA semaglutida+liraglutida+dulaglutida+tirzepatide + SGLT2i empagliflozin+dapagliflozin+canagliflozin + insulina basal+r\u00e1pida+ultrarr\u00e1pida + metformina + glitazona+sulfonilur\u00e9ia+meglitinida+acarbose + levotiroxina Synthroid+T3+ATD metimazol+propiltiouracil + cetoconazol+osilodrostat Isturisa+pasireotide Signifor+ + alendronato+denosumab Prolia+romosozumab Evenity+teriparatide Forteo+abaloparatide Tymlos osteoporose + testosterona Nebido+Testopatch+TRT + estradiol+progesterona TRT menopausa Lista B\/C5) + Grupo E (perfuro pen+seringa+agulha+lanceta capilar+CGM Dexcom G7+Libre 3+sensor 10-14d+bomba CSII Medtronic 780G+Tandem t:slim X2+Insulet Omnipod 5).<\/p>\n

Para o gestor que opera ou planeja cl\u00ednica de endocrinologia adulto, \u00e9 fundamental dimensionar RSS espec\u00edfico desde o in\u00edcio.<\/p>\n

Os 5 fluxos endocrinol\u00f3gicos adulto<\/h2>\n

Em uma opera\u00e7\u00e3o de qualquer porte, o RSS endo adulto tem 5 fluxos.<\/p>\n\n\n\n\n\n\n\n\n\n
Fluxo<\/th>\nVolume<\/th>\nFrequ\u00eancia<\/th>\nParticularidade<\/th>\n<\/tr>\n<\/thead>\n
DM2+obesidade<\/td>\n5-13 kg\/dia<\/td>\nDi\u00e1ria<\/td>\nGLP-1+SGLT2i+tirzep<\/td>\n<\/tr>\n
Tireoide+n\u00f3dulo<\/td>\n3-9 kg\/dia<\/td>\nDi\u00e1ria<\/td>\nLevo+ATD+RAI<\/td>\n<\/tr>\n
Adrenal+pituit\u00e1ria<\/td>\n1,5-4,5 kg\/dia<\/td>\nDi\u00e1ria<\/td>\nCushing+Addison+PRL<\/td>\n<\/tr>\n
Osteoporose+hipogon<\/td>\n2-6 kg\/dia<\/td>\nDi\u00e1ria<\/td>\nDenosumab+TRT<\/td>\n<\/tr>\n
Insulina+CGM+CSII<\/td>\n3-9 kg\/dia<\/td>\nDi\u00e1ria<\/td>\nTresiba+Dexcom+Omnipod<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

A soma t\u00edpica \u00e9 14,5-41,5 kg\/dia<\/strong> em cl\u00ednica endo adulto m\u00e9dia porte.<\/p>\n

DM2 + obesidade + GLP-1 + tirzepatide + SGLT2i + insulina: o est\u00e1gio metab\u00f3lico<\/h2>\n

A primeira camada \u00e9 DM2+obesidade. Padr\u00e3o setorial inclui (a) DM2 diagn\u00f3stico ADA 2024+SBD<\/strong> com glicemia jejum \u2265126 + 2h TOTG \u2265200 + HbA1c \u22656,5% + glicemia random \u2265200 + sintomas; (b) GLP-1 RA glucagon-like peptide-1 receptor agonist<\/strong> com semaglutida Ozempic Novo Nordisk 0,5-2mg SC q1w DM2 + Rybelsus oral 7-14mg\/d + Wegovy obesidade 2,4mg q1w STEP-1+SELECT CV + liraglutida Victoza 0,6-1,8mg\/d Saxenda obesidade 3mg + dulaglutida Trulicity Lilly 0,75-4,5mg q1w + exenatide Bydureon AstraZeneca q1w; (c) tirzepatide Mounjaro Lilly DM2\/Zepbound obesidade GLP-1+GIP dual<\/strong> 2,5-15mg SC q1w SURPASS-1\/2\/3\/4\/5+SURMOUNT-1\/2\/3\/4 perda peso 22% > Ozempic 15% + retatrutide LY3437943 GIP+GLP-1+glucagon triple TRIUMPH fase 3 perda peso ~24%; (d) SGLT2i sodium-glucose cotransporter 2 inhibitor<\/strong> com empagliflozin Jardiance Boehringer EMPA-REG OUTCOME CV+EMPEROR-Reduced HF+EMPA-KIDNEY DRC + dapagliflozin Forxiga AstraZeneca DAPA-HF+DAPA-CKD + canagliflozin Invokana Janssen CANVAS; (e) insulina basal+r\u00e1pida<\/strong> com basal Tresiba degludec U-100\/200 + Toujeo glargina U-300 + Lantus glargina U-100 + Levemir detemir + r\u00e1pida Lispro Humalog\/Asparte NovoRapid\/Glulisina Apidra + ultrarr\u00e1pida Fiasp asparte+ + Lyumjev lispro-aabc.<\/p>\n

Cl\u00ednica com DM2+obesidade+GLP-1+SGLT2i madura escala HbA1c <7% 70-80%<\/strong> + escala perda peso 15-24% tirzepatide+retatrutide<\/strong> + escala redu\u00e7\u00e3o CV 20-30% SELECT+EMPEROR<\/strong>. Como discutimos no post sobre endo pedi\u00e1trica<\/a>, endo adulto \u00e9 base.<\/p>\n

Tireoide hipo+hiper+n\u00f3dulo + adrenal+pituit\u00e1ria + Cushing+Addison: o est\u00e1gio glandular<\/h2>\n

A segunda camada \u00e9 tireoide+adrenal+pituit\u00e1ria. Padr\u00e3o setorial inclui (a) tireoide hipo Hashimoto<\/strong> com anti-TPO+anti-Tg+TSH\u2191+T4L\u2193+levotiroxina Synthroid Merck 1,6 \u00b5g\/kg\/d titrate TSH alvo 0,5-2,0 mUI\/L; (b) tireoide hiper Graves<\/strong> com TRAb+TSH\u2193+T4L\u2191+T3\u2191+ATD antithyroid drug metimazol Tapazol 10-30mg+propiltiouracil PTU 100-300mg + RAI radioiodine I-131 abla\u00e7\u00e3o + tireoidectomia + propranolol sintom\u00e1tico; (c) n\u00f3dulo tireoideano<\/strong> com TI-RADS 1-5 + Bethesda I-VI + FNAC fine needle aspiration cytology + Afirma+ThyroSeq molecular + cirurgia\/observa\u00e7\u00e3o; (d) adrenal Cushing end\u00f3geno+ex\u00f3geno<\/strong> com cortisol salivar+urin\u00e1rio 24h+supress\u00e3o dexametasona + cetoconazol Nizoral + metirapona Metopirone + osilodrostat Isturisa Recordati + pasireotide Signifor LAR Novartis + cirurgia adrenalec+pituit\u00e1ria; (e) adrenal Addison + pituit\u00e1ria panhipopituitarismo<\/strong> com hidrocortisona Cortef 15-25mg\/d + fludrocortisona Florinef + hormonios reposi\u00e7\u00e3o GH+LH\/FSH+TSH+ACTH; PRL prolactinoma<\/strong> cabergolina Dostinex+bromocriptina Parlodel; acromegalia GH<\/strong> octreotide LAR+lanreotide Somatuline+pasireotide+pegvisomant Somavert+lemioglucan + somavert Lista B\/C5.<\/p>\n

Cl\u00ednica com tireoide+adrenal+pituit\u00e1ria madura escala diagn\u00f3stico precoce hipo\/hiper<\/strong> + escala Cushing remiss\u00e3o osilodrostat+pasireotide<\/strong> + escala prolactinoma cabergolina remiss\u00e3o 70-90%<\/strong>. Conex\u00e3o com adrenal<\/a>.<\/p>\n

Osteoporose denosumab+romosozumab + hipogonadismo TRT + menopausa: o est\u00e1gio metab\u00f3lico+gonadal<\/h2>\n

A terceira camada \u00e9 osteo+hipogonadismo+menopausa. Padr\u00e3o setorial inclui (a) osteoporose p\u00f3s-menopausa+homem<\/strong> com DXA T-score \u2264-2,5 + FRAX score 10y fratura major+quadril + bisfosfonato alendronato Fosamax+risedronato Actonel+zoledronato Aclasta IV q12m + denosumab Prolia Amgen RANKL 60mg SC q6m + romosozumab Evenity Amgen anti-sclerostin 210mg SC q1m \u00d7 12 ARCH; (b) osteoporose anab\u00f3lico<\/strong> com teriparatide Forteo Lilly PTH 1-34 + abaloparatide Tymlos Radius PTHrP analog 80 \u00b5g SC QD ACTIVE+Forsteo+Tymlos sequ\u00eancia denosumab\/bisfosfonato; (c) hipogonadismo masculino LOH late-onset hypogonadism<\/strong> com testosterona total <300 ng\/dL + LH+FSH+SHBG + TRT testosterone replacement therapy gel AndroGel+Testim + injet\u00e1vel Nebido undecanoato 1.000mg q10-14sem + Testopatch transd\u00e9rmico + risco prost\u00e1tica+CV TRAVERSE; (d) menopausa<\/strong> com TRH terapia reposi\u00e7\u00e3o hormonal estradiol+progesterona micronizada + tibolona + drospirenona+estradiol Angeliq + Combiseven + t\u00f3pico vaginal estradiol + Lyrica\/SSRI sintom\u00e1ticos; (e) outros<\/strong> SOP feminino+contracep\u00e7\u00e3o+DM gestacional+puberdade tardia+Klinefelter+Turner+Kallmann.<\/p>\n

Cl\u00ednica com osteo+hipogon+menopausa madura escala redu\u00e7\u00e3o fratura denosumab 70%+romosozumab 50% adicional<\/strong> + escala TRT testosterona alvo 400-700<\/strong> + escala TRH menopausa qualidade vida<\/strong>. Conex\u00e3o com Lista C5<\/a>.<\/p>\n

Tr\u00eas perfis de RSS por capacidade endo adulto<\/h2>\n

Cl\u00ednica endo b\u00e1sica.<\/strong> 2 fluxos. Custo mensal R$ 12.000-32.000<\/strong> mas perda de tirzepatide+SGLT2i+osteo+TRT.<\/p>\n

Cl\u00ednica endo m\u00e9dia.<\/strong> 3 fluxos. Custo mensal R$ 24.000-58.000<\/strong>, captura DM2+tireoide+adrenal.<\/p>\n

Cl\u00ednica endo completa 5 fluxos.<\/strong> DM2+tireoide+adrenal+osteo+insulina + integra\u00e7\u00e3o com servi\u00e7os hospitalares<\/a>. Custo mensal R$ 45.000-105.000<\/strong>, efic\u00e1cia 95%, ROI 800-2.500% via captura endo + GLP-1+tirzepatide+SGLT2i+denosumab targeted.<\/p>\n

Os tr\u00eas erros que aparecem em endo adulto<\/h2>\n

O primeiro \u00e9 a subdimensionamento GLP-1+tirzepatide+SGLT2i Lista C5<\/strong>. Sem segrega\u00e7\u00e3o Ozempic+Wegovy+Mounjaro+Zepbound+Trulicity+Saxenda+Jardiance+Forxiga+Invokana + Lista C5 = n\u00e3o-conformidade ANVISA RDC 222 + risco contamina\u00e7\u00e3o cruzada profissional + impacto financeiro R$ 600-1.500\/m\u00eas\/paciente.<\/p>\n

O segundo \u00e9 a mistura DM2 + obesidade + tireoide + adrenal + pituit\u00e1ria<\/strong>. Confunde rastreabilidade end\u00f3crina + impossibilita protocolos espec\u00edficos ADA\/SBD + risco prescri\u00e7\u00e3o inadequada (GLP-1 vs SGLT2i vs insulina vs metformina).<\/p>\n

O terceiro \u00e9 a falta de protocolo screening rotineiro DM2+osteoporose+TRT<\/strong>. Sem HbA1c anual >35a + DXA p\u00f3s-menopausa+homem 65a + testosterona LOH + TSH 35a screening = subdiagn\u00f3stico 30-50% + risco complica\u00e7\u00e3o tardia.<\/p>\n

A regula\u00e7\u00e3o de RSS endo adulto no Brasil est\u00e1 em fase de moderniza\u00e7\u00e3o t\u00e9cnica acelerada com endocrinologia especializada como prioridade. As institui\u00e7\u00f5es que estruturam fluxos completos desde o in\u00edcio \u2014 alinhadas com calend\u00e1rio 2026 de compliance<\/a> \u2014 atravessam o crescimento sem solavanco. Para gestores que precisam alinhar com gest\u00e3o paralela industrial, o portal Seven Res\u00edduos sobre servi\u00e7os completos<\/a> traz a perspectiva integrada. A SBEM Sociedade Brasileira Endocrinologia<\/a> \u00e9 refer\u00eancia t\u00e9cnica nacional.<\/p>\n

Solicite cota\u00e7\u00e3o RSS endo adulto 5 fluxos completos<\/a><\/strong> \u2014 cap\u00edtulo dedicado a DM2 ADA 2024+SBD+glicemia jejum+TOTG+HbA1c+GLP-1 RA semaglutida Ozempic Novo Nordisk SC q1w+Rybelsus oral+Wegovy obesidade STEP-1+SELECT CV+liraglutida Victoza\/Saxenda+dulaglutida Trulicity Lilly+tirzepatide Mounjaro\/Zepbound GLP-1+GIP dual SURPASS+SURMOUNT perda peso 22%+retatrutide LY3437943 GIP+GLP-1+glucagon triple TRIUMPH+SGLT2i empagliflozin Jardiance Boehringer EMPA-REG+EMPEROR+EMPA-KIDNEY+dapagliflozin Forxiga AstraZeneca DAPA-HF+DAPA-CKD+canagliflozin Invokana CANVAS+insulina basal Tresiba degludec+Toujeo glargina U-300+Lantus+Levemir detemir+r\u00e1pida Lispro Humalog+Asparte NovoRapid+Glulisina Apidra+ultrarr\u00e1pida Fiasp+Lyumjev Lista C5, tireoide hipo Hashimoto anti-TPO+TgAb+levotiroxina Synthroid+hiper Graves TRAb+ATD metimazol Tapazol+PTU+RAI I-131+TI-RADS 1-5+Bethesda I-VI+FNAC+Afirma+ThyroSeq molecular, adrenal Cushing cortisol salivar+urin\u00e1rio 24h+supress\u00e3o dexa+cetoconazol+metirapona+osilodrostat Isturisa Recordati+pasireotide Signifor LAR Novartis+Addison hidrocortisona+fludrocortisona+pituit\u00e1ria PRL prolactinoma cabergolina Dostinex+bromocriptina+acromegalia GH octreotide LAR+lanreotide Somatuline+pegvisomant Somavert, osteoporose DXA T-score\u2264-2,5+FRAX+alendronato Fosamax+risedronato+zoledronato Aclasta+denosumab Prolia Amgen RANKL+romosozumab Evenity Amgen anti-sclerostin ARCH+teriparatide Forteo PTH 1-34+abaloparatide Tymlos PTHrP ACTIVE, hipogonadismo LOH+TRT testosterona AndroGel+Testim+Nebido undecanoato+Testopatch+TRAVERSE+menopausa TRH estradiol+progesterona micronizada+tibolona+drospirenona+Lyrica\/SSRI sintom\u00e1ticos.<\/p>\n","protected":false},"excerpt":{"rendered":"

RSS endo adulto: DM2 + GLP-1 + tirzepatide + SGLT2i + obesidade. Veja.<\/p>\n","protected":false},"author":3,"featured_media":2269,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[3105,1953,1340,3106],"class_list":["post-2270","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-compliance-legislacao","tag-dm2","tag-endocrinologia","tag-glp-1","tag-tirzepatide"],"_links":{"self":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts\/2270","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/comments?post=2270"}],"version-history":[{"count":1,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts\/2270\/revisions"}],"predecessor-version":[{"id":4358,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts\/2270\/revisions\/4358"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/media\/2269"}],"wp:attachment":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/media?parent=2270"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/categories?post=2270"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/tags?post=2270"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}